Solution structure of recombinant human interleukin-6

Journal of Molecular Biology

Volumn 268, Issue 2, 1997, Pages 468-481

  Xu, Guang Yi ^a   Yu, Hsiang Ai ^a   Hong, Jin ^a   Stahl, Mark ^a   McDonagh, Thomas ^a   Kay, Lewis E ^b   Cumming, Dale A ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cytokine; IL 6; Mutagenesis; NMR structure

Indexed keywords

INTERLEUKIN 6;

ARTICLE; CELL LINE; CRYSTAL STRUCTURE; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE;

EID: 0031547958     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.0933     Document Type: Article

References (81)

1. 13C J couplings in a 20-kDa protein-peptide complex. J. Am. Chem. Soc. 114:1992;6924-6924.
2. Bax A., Delaglio F., Grzesiek S., Vuister G., W. Resonance assignment of methionine methyl groups and χ3 angular information from long-range proton-carbon and carbon-carbon J correlation in a calmodulin-peptide complex. J. Biomol. NMR. 4:1994;787-797.
3. Brakenhoff J. P., de Hon F. D., Fontaine V., ten Boekel E., Schooltink H., Rose-John S., Heinrich P. C., Content J., Aarden L. A. Development of a human interleukin-6 receptor antagonist. J. Biol. Chem. 269:1994;86-93.
4. Brakenhoff J. P., de Hon F. D., Aarden L. A. Development of human IL-6 receptor antagonists. Ann. NY Acad. Sci. 762:1995;129-134.
5. Brooks B. R., Bruccoleri R. E., Olafson B. D., States D. J., Swaminathan S., Karplus M. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4:1983;187-217.
6. Brünger, A. T. 1993, X-PLOR Version 3.1: A System for X-ray Crystallography and NMR, Yale University Press, New Haven, CT.
7. Carson M. Ribbons 2.0. J. Appl. Crystallog. 24:1991;958-961.
8. Chothia C., Levitt M., Richardson D. Helix to helix packing in proteins. J. Mol. Biol. 145:1981;215-250.
9. Ciapponi L., Graziani R., Paonessa G., Lahm A., Ciliberto G., Savino R. Definition of a composite binding site for gp130 in human interleukin-6. J. Biol. Chem. 270:1995;31249-31254.
10. Clore G. M., Gronenborn A. M., Nilges M., Ryan C. A. Three-dimensional structure of potato carboxypeptidase inhibitor in solution. A study using nuclear magnetic resonance, distance geometry, and restrained molecular dynamics. Biochemistry. 26:1987;8012-8013.
11. Clore G. M., Kay L. E., Bax A., Gronenborn A. M. High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four dimensional nuclear magnetic resonance spectroscopy. Biochemistry. 30:1991;12-18.
12. Davis S., Aldrich T. H., Stahl N., Pan L., Taga T., Kishimoto T., Ip N. Y., Yancopoulos G. D. LIFRβ and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science. 260:1993;1805-1808.
13. de Hon F. D., Ehlers M., Rose-John S., Ebeling S. B., Bos H. K., Aarden L. A., Brakenhoff J. P. Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells. J. Expt. Med. 180:1994;2395-2400.
14. de Hon F. D., ten Boekel E., Herrman J., Clement C., Ehlers M., Taga T., Yasukawa K., Ohsugi Y., Kishimoto T., Rose-John S., Wijdenes J., Kastelein R., Aarden L. A., Brakenhoff J. P. Functional distinction of two regions of human interleukin 6 important for signal transduction via gp130. Cytokine. 7:1995;398-407.
15. Delaglio F., Grzesiek S., Vuister G. W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensioanl spectral processing system based on UNIX pipes. J. Biomol. NMR. 6:1995;277-293.
16. De Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 255:1992;306-312.
17. Ehlers M., Grotzinger J., deHon F. D., Mullberg J., Brakenhoff J. P., Liu J., Wollmer A., Rose-John S. Identification of two novel regions of human il-6 responsible for receptor binding and signal transduction. J. Immunol. 153:1994;1744-1753.
18. Feng D. F., Doolittle R. F. Progressive sequence alignment as a prerequisite to correctphylogenetic trees. J. Mol. Evol. 25:1987;351-360.
19. 1H nuclear magnetic resonance spectroscopy. Biochemistry. 29:1990;1566-1572.
20. Garrett D. S., Powers R., Gronenborn A. M., Clore G. M. A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams. J. Magn. Reson. 95:1991;214-220.
21. Garrett D. S., Kuszewski J., Hancoca T. J., Lodi P. J., Vuister G. W., Gronenborn A. M., Clore G. M. The impact of direct refinement against three-bond HN-CαH coupling constants on protein structure determination by NMR. J. Magn. Reson. ser. B. 104:1994;99-103.
22. Gustchina A., Zdanov A., Schalk-Hihi C., Wlodawer A. A model of the complex between interleukin-4 and its receptors. Proteins: Struct. Funct. Genet. 21:1995;140-148.
23. Hill C. P., Osslund T. D., Eisenberg D. The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. Proc. Natl Acad. Sci., USA. 90:1993;5167-5171.
24. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., Tsunasawa S., Sakiyama F., Matsui H., Takahara Y., Taniguchi T., Kishimoto T. Complementary DNA for a novel human interleukin (BSF-2) that induces lymphocytes to produce immunoglobulin. Nature. 324:1986;73-76.
25. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today. 11:1990;443-449.
26. Hudson K. R., Vernallis A. B., Heath J. K. Characterization of the receptor binding sites of human leukemia inhibitory factor and the creation of antagonists. J. Biol. Chem. 271:1996;11971-11978.
27. Humphrey W., Dalke A., Schulten K. VDM: visual molecular dynamics. J. Mol. Graph. 14:1996;33-38.
28. Inoue M., Nakayama C., Kikuchi K., Kimura T., Ishige Y., Ito A., Kanaoka M., Noguchi H. D1 cap region involved in the receptor recognition and neural cell survival activity of human ciliary neurotrophic factor. Proc. Natl Acad. Sci. USA. 92:1995;8579-8583.
29. Ishimi Y., Miyaura C., Jin C. H., Akatsu T., Abe E., Nakamura Y., Yamaguchi A., Yoshiki S., Matsuda T., Hirano T., Kishimoto T., Suda T. IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 145:1990;3297-3303.
30. Ivashkiv L. B. Cytokines and STATs: how can signals achieve specificity? Immunity. 3:1995;1-14.
31. Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 332:1988;83-85.
32. Kay L. E. Pulsed field gradient multi-dimensional NMR methods for the study of protein structure and dynamics in solution. Prog. Biophys. Mol. Biol. 63:1995;110-126.
33. 15N-labeled proteins. J. Magn. Reson. 86:1990;110-126.
34. King D. P., Schrenzel M. D., McKnight M. L., Reidarson T. H., Hanni K. D., Stott J. L., Ferrick D. A. Molecular cloning and sequencing of interleukin 6 cDNA fragments from the harbor seal (Phoca vitulina), killer whale (Orcinus orca), and Southern sea otter (Enhydra lutris nereis). Immunogentics. 43:1995;190-195.
35. Kishimoto T. The biology of interleukin-6. Blood. 74:1989;1-10.
36. Kishimoto T., Akira S., Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 258:1992;593-597.
37. Kraulis P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
38. Kruse N., Shen B. J., Arnold S., Tony H. P., Muller T., Sebald W. Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J. 12:1993;5121-5129.
39. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-291.
40. Laskowski R. A., Rullman J. A. C., MacArthur M. W., Kaptein R., Thorton J. M. "AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR. 8:1996;477-486.
41. Layton M. J., Owczarek C. M., Metcalf D., Clark R. L., Smith D. K., Treutlein H. R., Nicola N. A. Conversion of the biological specificity of murine to human leukemia inhibitory factor by replacing 6 amino acid residues. J. Biol. Chem. 269:1994;29891-29896.
42. Mawatari M., Kohno K., Mizoguchi H., Matsuda T., Asoh K., Van Damme J., Welgus H. G., Kuwano M. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells. J. Immunol. 143:1989;1619-1627.
43. McDonald N. Q., Panayotatos N., Hendrickson W. A. Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing. EMBO J. 14:1995;2689-2699.
44. Morrison B. W., Leder P. A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis. J. Biol. Chem. 267:1992;11957-11963.
45. Mott H. R., Campbell I. D. The solution structure of the F42A mutant of human interleukin 2. Curr. Opin. Struct. Biol. 5:1995;114-121.
46. Muhandiram D. R., Kay L. E. Gradient-enhanced triple-resonance three-dimensional NMR experiments with improved sensitivity. J. Magn. Reson. ser. B. 103:1994;203-216.
47. Muller T., Dieckmann T., Sebald W., Oschkinat H. Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and NMR spectroscopy. J. Mol. Biol. 237:1994;423-436.
48. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 260:1993;1808-1810.
49. Needleman S. B., Wunch C. D. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48:1970;443-453.
50. Nilges M., Clore G. M., Gronenborn A. M. Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms. Circumventing problems associated with folding. FEBS Letters. 229:1988;317-324.
51. Orita T., Oh-eda M., Hasegawa M., Kuboniwa H., Esaki K., Ochi N. Polypeptide and carbohydrate structure of recombinant human interleukin-6 produced in Chinese hamster ovary cells. J. Biochem. 115:1994;345-350.
52. Panayotatos N., Radziejewska E., Acheson A., Somogyi R., Thadani A., Hendrickson W. A., McDonald N. Q. Localization of functional receptor epitopes on the structure of ciliary neurotrophic factor indicates a conserved, function-related epitope topography among helical cytokines. J. Biol. Chem. 270:1995;14007-14014.
53. Paonessa G., Graziani R., De Serio A., Savino R., Ciapponi L., Lahm A., Salvati A. L., Toniatti C., Ciliberto G. Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling. EMBO J. 14:1995;1942-1951.
54. Pascal S. M., Muhandiram D. R., Yamazaki T., Forman-Kay J. D., Kay L. E. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. J. Magn. Reson. ser. B. 103:1994;197-201.
55. Powers R., Gronenborn A. M., Clore G .M., Bax A. Three dimensional triple resonance NMR of 13C/15N enriched proteins using constant time evolution. J. Magn. Reson. 94:1991;209-213.
56. Powers R., Garrett D. S., March C. J., Frieden E. A., Gronenborn A. M., Clore G. M. The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy. Biochemistry. 32:1993;6744-6752.
57. Robinson R. C., Grey L. M., Staunton D., Vankelecom H., Vernallis A. B., Moreau J. F., Stuart D. I., Heath J. K., Jones E. Y. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell. 77:1994;1101-1116.
58. Sali A., Potterton L., Yuan F., van Vlijmen H., Karplus M. Evaluation of comparative protein modeling by MODELLER. Proteins: Struct. Funct. Genet. 23:1995;318-326.
59. Savino R., Lahm A., Giorgio M., Cabibbo A., Tramontano A., Ciliberto G. Saturation mutagenesis of the human interleukin 6 receptor binding site: implications for its three dimensional structure. Proc. Natl Acad. Sci., USA. 90:1993;4067-4071.
60. Savino R., Ciapponi L., Lahm A., Demartis A., Cabibbo A., Toniatti C., Delmastro P., Altamura S., Ciliberto G. Rational design of a receptor super-antagonist of human interleukin-6. EMBO J. 13:1994a;5863-5870.
61. Savino R., Lahm A., Salvati A. L., Ciapponi L., Sporeno E., Altamura S., Paonessa G., Toniatti C., Ciliberto G. Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation. EMBO J. 13:1994b;1357-1367.
62. Senda T., Shimazu T., Matsuda S., Kawano G., Shimizu H., Nakamura K. T., Mitsui Y. Three-dimensional crystal structure of recombinant murine interferon-beta. EMBO J. 11:1992;3193-3201.
63. Somers W., Stahl M., Seehra J. 1.9 Å Crystal structure of interleukin 6: implications for a novel mode of receptor dimerisation and signalling. EMBO J. 5:1997;989-997.
64. Sprang S. R., Bazan J. F. Cytokine structural taxonomy and mechanisms of receptor engagement. Curr. Opin. Struct. Biol. 3:1993;815-827.
65. Starnes H. F., Pearce M. K., Tewari A., Yim J. H., Zou J.-C., Abrams J. S. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J. Immunol. 145:1990;4185-4191.
66. Sutcliffe M. J., Haneef I., Carney D., Blundell T. L. Knowledge-based modeling of homologous proteins. Part I: three-dimensional frameworks derived from the simultaneous superposition of multiple structures. Protein Eng. 1:1987;377-384.
67. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:1989;573-581.
68. Thier M., Simon R., Kruttgen A., Rose-John S., Heinrich P. C., Schroder J. M., Weis J. Site-directed mutagenesis of human CNTF: functional analysis of recombinant variants. J. Neurosci. Res. 40:1995;826-835.
69. Ultsch M. H., Somers W., Kossiakoff A. A., de Vos A. M. The crystal structure of affinity-matured human growth hormone at 2 Å resolution. J. Mol. Biol. 236:1994;286-299.
70. Van Damme J., Opdenakker G., Simpson R. J., Rubira M. R., Cayphas S., Vink A., Billiau A., Van Snick J. Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J. Expt. Med. 165:1987;914-919.
71. 15N-enriched proteins. J. Am. Chem. Soc. 115:1993;7772-7777.
72. Vuister G. W., Clore G. M., Gronenborn A. M., Powers R., Garrett D. S., Tschudin R., Bax A. Increased resolution and improved spectral quality in four-dimensional carbon-13/carbon-13-separated HMQC-NOESY-HMQC spectra using pulsed field gradients. J. Magn. Reson. ser. B. 101:1993;210-213.
73. Wagner G., Braun W., Havel T. F., Schaumann T., Go N., Wüthrich K. Protein structures in solution by nuclear magnetic resonance and distance geometry. The polypeptide fold of the basic pancreatic trypsin inhibitor determined using two different algorithms, DISGEO and DISMAN. J. Mol. Biol. 196:1987;611-639.
74. Ward L. D., Howlett G. J., Discolo G., Yasukawa K., Hammacher A., Moritz R. L., Simpson R. J. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J. Biol. Chem. 269:1994;23286-23289.
75. Wells J. A., DeVos A. M. Hematopoietic receptor complexes. Annu. Rev. Biochem. 65:1996;609-634.
76. Wüthrich K. NMR of Proteins and Nucleic Acids. 1986;John Wiley, New York.
77. Xu G. Y., Ong E., Gilkes N. R., Kilburn D. G., Muhandiram D. R., Harris-Brandts M., Carver J. P., Kay L. E., Harvey T. S. Solution structure of a cellulose-binding domain from Cellulomonas fimi by nuclear magnetic resonance spectroscopy. Biochemistry. 34:1995;6993-7009.
78. 13C assignments, secondary structure, and topology of recombinant human interleukin-6. J. Biomol. NMR. 8:1996;123-135.
79. Zhu G., Bax A. Improved linear prediction of damped NMR signals using modified "forward-backward" linear prediction. J. Magn. Reson. 100:1992;202-207.
80. Zink T., Ross A., Luers K., Cieslar C., Rudolph R., Holak T. A. Structure and dynamics of the human granulocyte colony-stimulating factor determined by NMR spectroscopy. Loop mobility in a four-helix-bundle protein. Biochemistry. 33:1994;8453-8463.
81. 1H) HMQC-NOE-HMQC NMR spectroscopy: resolving tertiary nuclear Overhauser effect distance constraints in the spectra of larger proteins. J. Am. Chem. Soc. 113:1991;370-371.